Related Experiment Videos
Vagal nerve stimulation in children.
1EEG and Pediatric Epilepsy Monitoring Unit, University of Pittsburgh School of Medicine, PA 15213-2583, USA.
Seminars in Pediatric Neurology
|October 7, 2000
Summary
Vagal nerve stimulation (VNS) shows promise for children with epilepsy refractory to medication. Further research is needed to define optimal patient selection and stimulation parameters for this growing pediatric population.
Area of Science:
- Neurology
- Pediatric Epilepsy
- Neurostimulation
Background:
- Vagal nerve stimulation (VNS) is an emerging therapy for medically refractory epilepsy.
- The NeuroCybernetic Prosthesis (NCP) was FDA-approved in 1997 for adolescents and adults.
- Pediatric use of VNS has increased, with initial data suggesting efficacy and safety in children unresponsive to antiepileptic drugs.
Purpose of the Study:
- To address key questions regarding the use of VNS in pediatric epilepsy.
- To guide the selection and treatment of children with refractory epilepsy using VNS.
Main Methods:
- Review of initial data from open-label, uncontrolled studies on pediatric VNS.
- Analysis of existing literature and clinical experience.
Main Results:
- VNS demonstrates potential efficacy and safety in children with refractory epilepsy.
- Further investigation is required to establish specific criteria and parameters.
Conclusions:
- VNS is a viable therapeutic option for pediatric refractory epilepsy.
- Key areas for future research include defining medical refractoriness, selection criteria, optimal stimulation parameters, and responsive seizure types/syndromes in children.